Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Betel Del Rosario García"'
Autor:
Betel, Del Rosario-García, Gloria Julia, Nazco-Casariego, Juan Luis, Gómez-Sirvent, Rosa, García-Marrero, Dácil, García-Rosado, Ana María, López-Lirola, Juana María, Oramas-Rodríguez, Jonathan, González-García
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(3)
To analyse the effectiveness and safety of daptomycin versus vancomycin on the management catheter-related bloodstream nfections in oncology patients.A retrospective study was carried out including all patients admitted at the Medical Oncology Unit b
Autor:
María Micaela Viña Romero, Ruth Ramos Díaz, Betel Del Rosario García, Alejandro Jiménez Sosa, José Alberto Morales Barrios, Juana M Oramas Rodríguez, Gloria Julia Nazco Casariego, Fernando Gutiérrez Nicolás
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:530-534
Introduction Patient-reported outcomes (PROs) use, via a computer registry, allows patients to report their symptoms enabling the detection of early signs of progression of the disease. For such a record, the patient needs to show certain skills in n
Autor:
Betel Del Rosario García, José Alberto Morales Barrios, Josefina Cruz Jurado, Ruth Ramos Díaz, María Micaela Viña Romero, Ivette Mourani Padrón, Gloria Julia Nazco Casariego, Fernando Gutiérrez Nicolás
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211437
Objectives Imatinib is the first therapeutic option for the treatment of unresectable or metastatic gastrointestinal stromal tumours. Previous studies have shown an improvement in patient survival rates following the use of imatinib. Nevertheless, ad
Autor:
Betel Del Rosario García, Jonathan González García, Fernando Gutiérrez Nicolás, Iris González García, Ruth Ramos Díaz, Sunil Lakhwani Lakhwani, Ivette Mourani Padrón, María Micaela Viña Romero, Gloria Julia Nazco Casariego
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
Introduction The addition of imatinib to the therapeutic arsenal for chronic myeloid leukaemia (CML) has changed the natural course of the disease, in such a way that it is now considered a chronic pathology. However, to achieve therapeutic success,
Autor:
Betel Del Rosario García, Barrios, José Alberto Morales, Romero, María M Viña, Díaz, Ruth Ramos, Casariego, Gloria J Nazco, Sosa, Alejandro Jiménez, Rodríguez, Juana M Oramas, Nicolás, Fernando Gutiérrez
Supplemental material, sj-pdf-1-opp-10.1177_1078155221996041 for Patient-reported outcomes and digital literacy of patients treated in an oncology day hospital unit by Betel José Alberto Morales Barrios, María M Viña Romero, Ruth Ramos Díaz Glori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a5b8c240618330dd7db51d243a0c599
Autor:
Betel Del Rosario García, Barrios, José Alberto Morales, Romero, María M Viña, Díaz, Ruth Ramos, Casariego, Gloria J Nazco, Sosa, Alejandro Jiménez, Rodríguez, Juana M Oramas, Nicolás, Fernando Gutiérrez
Supplemental material, sj-pdf-1-opp-10.1177_1078155221996041 for Patient-reported outcomes and digital literacy of patients treated in an oncology day hospital unit by Betel José Alberto Morales Barrios, María M Viña Romero, Ruth Ramos Díaz Glori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a01ea83f1cd756e4d625d4ec71186f8